USPTO serial 90149471
DOSEID
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- MURRAY, DAVID T
- Law office
- TMO LAW OFFICE 113 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with DOSEID?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Ashly Boesche
Ashly Boesche Pattishall, McAuliffe, Newbury, Hilliard & Geralds200 S. Wacker Drive, Suite 2900Chicago, IL 60606UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| A | Serialized and radio-frequency identification (RFID) tagged pharmaceuticals, pharmaceutical preparations, and medical supplies; Radio-frequency identification (RFID) tags; Labels for pharmaceuticals, pharmaceutical preparations, and medical supplies; Radio-frequency identification (RFID) scanning readers for tracking, dispensing, and taking inventory of pharmaceuticals, pharmaceutical preparations, and medical supplies; Computer hardware and operating software for tracking, dispensing, and taking inventory of pharmaceuticals, pharmaceutical preparations, and medical supplies; Computer hardware and operating software for clinical decision support | ACTIVE | — |
| B | Providing temporary use of non-downloadable computer software for tracking and taking inventory of pharmaceuticals, pharmaceutical preparations, and medical supplies; Providing temporary use of non-downloadable computer software for auditing medical records and medication dispensing systems; Providing temporary use of non-downloadable computer software for reporting data in medical records and medication dispensing systems; Providing temporary use of non-downloadable computer software for assessing and reviewing data in medical records and medication dispensing systems to formulate a discrepancy resolution process; Providing temporary use of non-downloadable computer software for implementing industry standards in connection with pharmaceuticals, pharmaceutical preparations, medical records, medication dispensing systems, and medical supplies; Providing temporary use of non-downloadable computer software for implementing industry standards in connection with tracking, dispensing, and taking inventory of pharmaceuticals, pharmaceutical preparations, and medical supplies; Providing temporary use of non-downloadable computer software for implementing industry standards in connection with tracking, auditing, assessing, reviewing, and reporting data in medical records and medication dispensing systems; Software as a service (SAAS) services featuring software for tracking and taking inventory of pharmaceuticals, pharmaceutical preparations, and medical supplies; Software as a service (SAAS) services featuring software for auditing medical records and medication dispensing systems; Software as a service (SAAS) services featuring software for reporting data in medical records and medication dispensing systems; Software as a service (SAAS) services featuring software for assessing and reviewing data in medical records and medication dispensing systems to formulate a discrepancy resolution process; Software as a service (SAAS) services featuring software for implementing industry standards in connection with pharmaceuticals, pharmaceutical preparations, medical records, medication dispensing systems, and medical supplies; Software as a service (SAAS) services featuring software for implementing industry standards in connection with tracking, dispensing, and taking inventory of pharmaceuticals, pharmaceutical preparations, and medical supplies; Software as a service (SAAS) services featuring software for implementing industry standards in connection with tracking, auditing, assessing, reviewing, and reporting data in medical records and medication dispensing systems; Developing quality control, usage, compatibility, and interoperability standards in connection with pharmaceuticals, pharmaceutical preparations, medical records, medication dispensing systems, and medical supplies; Developing quality control, usage, compatibility, and interoperability standards for tracking, dispensing, and taking inventory of pharmaceuticals, pharmaceutical preparations, and medical supplies; Developing quality control, usage, compatibility, and interoperability standards in connection with tracking, auditing, assessing, reviewing, and reporting data found in medical records and medication dispensing systems; Developing quality control, usage, compatibility, and interoperability standards in connection with pharmaceuticals, pharmaceutical preparations, medical records, medication dispensing systems, and medical supplies; Developing quality control, usage, compatibility, and interoperability standards in connection with tracking and taking inventory of pharmaceuticals, pharmaceutical preparations, and medical supplies; Developing quality control, usage, compatibility, and interoperability standards in connection with auditing medical records and medication dispensing systems; Developing quality control, usage, compatibility, and interoperability standards in connection with reporting data in medical records and medication dispensing systems; Developing quality control, usage, compatibility, and interoperability standards in connection with assessing and reviewing data in medical records and medication dispensing systems to formulate a discrepancy resolution process; Developing quality control, usage, compatibility, and interoperability standards in connection with implementing industry standards in connection with pharmaceuticals, pharmaceutical preparations, medical records, medication dispensing systems, and medical supplies; Developing quality control, usage, compatibility, and interoperability standards in connection with implementing industry standards in connection with tracking, dispensing, and taking inventory of pharmaceuticals, pharmaceutical preparations, and medical supplies; Developing quality control, usage, compatibility, and interoperability standards in connection with implementing industry standards in connection with tracking, auditing, assessing, reviewing, and reporting data in medical records and medication dispensing systems; Testing, analysis, and evaluation of the goods of others to assure compliance with industry standards; Providing authentication and verification services using computer hardware and software for pharmaceuticals, pharmaceutical preparations, medical dispensing systems, and medical supplies; Developing and maintaining a registry of approved identification numbers for use with an authentication and verification service for pharmaceuticals, pharmaceutical preparations, medication dispensing systems, and medical supplies; Creating and assigning identification numbers and radio frequency identification (RFID) tags for use with an authentication and verification service for pharmaceuticals, pharmaceutical preparations, medication dispensing systems, and medical supplies; Computer software licensing | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 1, 2022 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Apr 1, 2022 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Mar 22, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 12, 2021 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Nov 12, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 12, 2021 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Nov 3, 2021 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Nov 3, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 3, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 3, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 3, 2021 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Oct 25, 2021 | WOAG | WITHDRAWAL OF ATTORNEY GRANTED | — |
| Oct 25, 2021 | WOAR | TEAS WITHDRAWAL OF ATTORNEY RECEIVED | — |
| Oct 22, 2021 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Oct 22, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 22, 2021 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Aug 12, 2021 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Aug 12, 2021 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 12, 2021 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 3, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 2, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 2, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 9, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 9, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 9, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 4, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 5, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 3, 2020 | NWAP | NEW APPLICATION ENTERED | — |